---
$id: https://graph.org.ai/products/commodity/51141562
$type: Product
source: UNSPSC
code: "51141562"
title: "Ilepcimide"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ilepcimide

**UNSPSC Code**: 51141562
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C15H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5ML58O200F, chemically known as 1-(3-(1,3-benzodioxol-5-yl)-1-oxo-2-propenyl)piperidine but generally known as ilepcimide, which bears US NIH Compound Identifier 54930. European Medicines Agency schedules Ilepcimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08130MIG. The term ILEPCIMIDE is an International Non-Proprietary Name. ILEPCIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ilepcimide under HS 29349990 and SITC 51579. As of Q4 2014, ILEPCIMIDE remains the US FDA Preferred Term for this commodity. Ilepcimide bears US NLM identifiers UMLS ID C0284581 and NCI Concept Code C72810. SMILES: O=C(N1CCCCC1)/C=C/C1CC2OCOC2CC1.

